EFFECTS OF S-ADENOSYL-L-METHIONINE ON COLLAGEN EXPRESSION IN ACTIVATED HEPATIC STELLATE CELLS

Search for this publication on Google Scholar
Thompson, K. (2009). EFFECTS OF S-ADENOSYL-L-METHIONINE ON COLLAGEN EXPRESSION IN ACTIVATED HEPATIC STELLATE CELLS. Unc Charlotte Electronic Theses And Dissertations.
Download PDF

Abstract

Liver fibrosis is defined as the excessive accumulation of extracellular matrix (ECM) components, which can disrupt the normal liver microcirculation and lead to injury. Unresolved, hepatic fibrosis can progress to cirrhosis, an end-state liver disease. Hepatic stellate cells (HSCs) are the chief mediator of fibrosis in the liver. Normal HSCs are quiescent, store vitamin A, and regulate sinusoidal blood flow. Upon a noxious stimulus, HSCs transdifferentiate into a myofibroblast-like cell, proliferate, migrate to the site of injury, and secrete ECM components, in particular type I collagen. The antioxidant S-adenosyl-L-methionine (SAMe) was evaluated as a therapeutic agent for the modulation of type I collagen in activated HSCs. Treatment with SAMe resulted in a 91% reduction in type I collagen secretion, however there was no significant change in intracellular collagen protein or mRNA expression. SAMe also increased NF-kappaB activity, a redox-sensitive transcription factor. Blocking NF-kappaB with a dominant-negative form of IkappaBalpha abolished SAMe-mediated type I collagen inhibition in Rat-1 fibroblasts. Examination of post-transcriptional fate of procollagen mRNAs revealed polyubiquitination of intracellular type I collagen following administration of SAMe. The endoplasmic reticulum (ER) proteins Grp78 and protein disulfide isomerase (PDI) were also significantly decreased by SAMe following 24 hours of treatment. These findings may represent a novel mechanism for modulating type I collagen expression in activated HSCs. We also report the development of a "two-hit" model of hepatic fibrosis, utilizing the Lieber-DeCarli liquid ethanol diet with concomitant injections of 0.5 mg/kg LPS semi-weekly. After 8 weeks of ethanol and LPS, animals developed significant perivenular and perisinusoidal fibrosis. Treatment with 10 mg/kg of SAMe daily abolished ethanol and LPS-induced fibrosis with a decrease in oxidative stress, and expression of TGF-beta and the downstream signaling molecule Smad3. SAMe also attenuated established hepatic fibrosis in a BDL model. These findings suggest SAMe is effective as both a preventative and curative treatment for hepatic fibrosis, and our "two-hit" model of ethanol feeding with LPS administration is appropriate for investigating liver fibrosis.

Details
Author

Thompson, Kyle

Title

EFFECTS OF S-ADENOSYL-L-METHIONINE ON COLLAGEN EXPRESSION IN ACTIVATED HEPATIC STELLATE CELLS

Physical Description

1 online resource (182 pages) : PDF

Date

2009

Degree Granting Institution

University of North Carolina at Charlotte

Abstract

Liver fibrosis is defined as the excessive accumulation of extracellular matrix (ECM) components, which can disrupt the normal liver microcirculation and lead to injury. Unresolved, hepatic fibrosis can progress to cirrhosis, an end-state liver disease. Hepatic stellate cells (HSCs) are the chief mediator of fibrosis in the liver. Normal HSCs are quiescent, store vitamin A, and regulate sinusoidal blood flow. Upon a noxious stimulus, HSCs transdifferentiate into a myofibroblast-like cell, proliferate, migrate to the site of injury, and secrete ECM components, in particular type I collagen. The antioxidant S-adenosyl-L-methionine (SAMe) was evaluated as a therapeutic agent for the modulation of type I collagen in activated HSCs. Treatment with SAMe resulted in a 91% reduction in type I collagen secretion, however there was no significant change in intracellular collagen protein or mRNA expression. SAMe also increased NF-kappaB activity, a redox-sensitive transcription factor. Blocking NF-kappaB with a dominant-negative form of IkappaBalpha abolished SAMe-mediated type I collagen inhibition in Rat-1 fibroblasts. Examination of post-transcriptional fate of procollagen mRNAs revealed polyubiquitination of intracellular type I collagen following administration of SAMe. The endoplasmic reticulum (ER) proteins Grp78 and protein disulfide isomerase (PDI) were also significantly decreased by SAMe following 24 hours of treatment. These findings may represent a novel mechanism for modulating type I collagen expression in activated HSCs. We also report the development of a "two-hit" model of hepatic fibrosis, utilizing the Lieber-DeCarli liquid ethanol diet with concomitant injections of 0.5 mg/kg LPS semi-weekly. After 8 weeks of ethanol and LPS, animals developed significant perivenular and perisinusoidal fibrosis. Treatment with 10 mg/kg of SAMe daily abolished ethanol and LPS-induced fibrosis with a decrease in oxidative stress, and expression of TGF-beta and the downstream signaling molecule Smad3. SAMe also attenuated established hepatic fibrosis in a BDL model. These findings suggest SAMe is effective as both a preventative and curative treatment for hepatic fibrosis, and our "two-hit" model of ethanol feeding with LPS administration is appropriate for investigating liver fibrosis.

Genre

doctoral dissertations

Subjects--Topics

Biology
Cytology

Degree

Ph.D.

Keywords

Adomet
Alcohol
Hepatic Stellate Cell
Liver Fibrosis
S-Adenosylmethionine

Subject Area

Biology

Advisor(s)

Shrum, Laura

Committee Members

Huet, Yvette
McKillop, Iain
Nelson, Daniel
Lee, Charles

Degree Note

Thesis (Ph.D.)--University of North Carolina at Charlotte, 2009.

Rights Statement

This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). For additional information, see http://rightsstatements.org/page/InC/1.0/.

Rights Holder Information

Copyright is held by the author unless otherwise indicated.

Identifier

Thompson_uncc_0694D_10076

Permalink

http://hdl.handle.net/20.500.13093/etd:1629